alnylam pharmaceuticals glp-1 receptor agonist GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Glucagon-like Peptide-1 Receptor Agonists in

IGF-1 elevation is the primary mechanism through which full HGH increases the risk of insulin resistance, fluid retention, and certain growth-related effects at high doses

Back Heinrich, G, Gros, P, Lund, PK, et al (1984) 'Pre-Proglucagon Messenger Ribonucleic Acid: Nucleotide and Encoded Amino Acid Sequences of the rat pancreatic complementary deoxyribonucleic acid', Endocrinology , 115/6, 2176-81

In addition, the Supporting Factors such as sleep and hydration will materially affect results

Answer: Most reported side effects are mild and dose-related, including injection-site reactions, transient water retention, and occasional numbness or tingling